BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28612017)

  • 1. Treatment Options in Colorectal Liver Metastases: Hepatic Arterial Infusion.
    Zervoudakis A; Boucher T; Kemeny NE
    Visc Med; 2017 Mar; 33(1):47-53. PubMed ID: 28612017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting the biologic challenge of colorectal metastases.
    Wanebo HJ; LeGolvan M; Paty PB; Saha S; Zuber M; D'Angelica MI; Kemeny NE
    Clin Exp Metastasis; 2012 Oct; 29(7):821-39. PubMed ID: 23053740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial infusion in combination with systemic chemotherapy in patients with hepatic metastasis from colorectal cancer: a randomized phase II study - (NCT05103020) - study protocol.
    Kim JS; Kim H; Lee SY; Han YD; Han K; Min BS; Kim MD; Won JY; Beom SH; Shin SJ; Kim HS; Han DH; Ahn JB
    BMC Cancer; 2023 Jul; 23(1):691. PubMed ID: 37481515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer.
    Mocellin S; Pasquali S; Nitti D
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007823. PubMed ID: 19588444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases.
    Pernot S; Velut G; Kourie RH; Amouyal G; Sapoval M; Pointet AL; Landi B; Zaimi Y; Lepère C; Pellerin O; Taieb J
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):255-260. PubMed ID: 29233520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
    Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases.
    Boilève A; De Cuyper A; Larive A; Mahjoubi L; Najdawi M; Tazdait M; Gelli M; Tselikas L; Smolenschi C; Malka D; Pignon JP; Ducreux M; Boige V
    Eur J Cancer; 2020 Oct; 138():89-98. PubMed ID: 32871526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32).
    Kusano M; Aoyama T; Okabayashi K; Hirata K; Tsuji Y; Nakamori S; Asahara T; Ohashi Y; Yoshikawa T; Sakamoto J; Oba K; Saji S
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S761-S766. PubMed ID: 30249900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of hepatic arterial infusion (HAI) of floxuridine with modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresectable liver metastases from colorectal cancer.
    Li C; Gu Y; Zhao M; Yuan Y; Wang F; Wang Z; Li W; Luo H; Chen C; Chen G; Ding P; Wu X; Lu Z; Pan Z; Xu R; He Y; Wan D; Li Y
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1079-87. PubMed ID: 25217393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
    Boilève A; Maillard A; Wagner M; Dromain C; Laurent C; Dupont Bierre E; Le Sourd S; Audemar F; Ulusakarya A; Guerin-Meyer V; Smisth D; Pezzella V; De Baere T; Goere D; Gelli M; Taieb J; Boige V
    BMC Cancer; 2020 Jan; 20(1):74. PubMed ID: 32000724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49.
    Pernot S; Pellerin O; Mineur L; Monterymard C; Smith D; Lapuyade B; Gallois C; Khemissa Akouz F; De Baere T; Tougeron D; Thirot-Bidault A; Audemar F; Simon M; Lecaille C; Louafi S; Lepage C; Ducreux M; Taieb J
    Dig Liver Dis; 2022 Mar; 54(3):324-330. PubMed ID: 35027324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
    Goéré D; Deshaies I; de Baere T; Boige V; Malka D; Dumont F; Dromain C; Ducreux M; Elias D
    Ann Surg; 2010 Apr; 251(4):686-91. PubMed ID: 20224373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study.
    Ghiringhelli F; Vincent J; Bengrine L; Borg C; Jouve JL; Loffroy R; Guiu B; Blanc J; Bertaut A
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2357-2363. PubMed ID: 31273511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer.
    Kemeny N; Capanu M; D'Angelica M; Jarnagin W; Haviland D; Dematteo R; Fong Y
    Ann Oncol; 2009 Jul; 20(7):1236-41. PubMed ID: 19233901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen).
    Lorenz M; Müller HH; Schramm H; Gassel HJ; Rau HG; Ridwelski K; Hauss J; Stieger R; Jauch KW; Bechstein WO; Encke A
    Ann Surg; 1998 Dec; 228(6):756-62. PubMed ID: 9860474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
    Cercek A; Boerner T; Tan BR; Chou JF; Gönen M; Boucher TM; Hauser HF; Do RKG; Lowery MA; Harding JJ; Varghese AM; Reidy-Lagunes D; Saltz L; Schultz N; Kingham TP; D'Angelica MI; DeMatteo RP; Drebin JA; Allen PJ; Balachandran VP; Lim KH; Sanchez-Vega F; Vachharajani N; Majella Doyle MB; Fields RC; Hawkins WG; Strasberg SM; Chapman WC; Diaz LA; Kemeny NE; Jarnagin WR
    JAMA Oncol; 2020 Jan; 6(1):60-67. PubMed ID: 31670750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of hepatic arterial infusion of fluorouracil with leucovorin as salvage treatment for refractory liver metastases from colorectal cancer.
    Lee HJ; Lee YS; Lee KW; Kim SY; Yoon CJ; Shin DY; Lee YG; Choi SY; Kang SG; Kang SB; Kim JH
    Korean J Intern Med; 2011 Mar; 26(1):82-8. PubMed ID: 21437167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.